258 related articles for article (PubMed ID: 26017300)
1. Immunopotentiator-Loaded Polymeric Microparticles as Robust Adjuvant to Improve Vaccine Efficacy.
Zhang W; Wang L; Yang T; Liu Y; Chen X; Liu Q; Jia J; Ma G
Pharm Res; 2015 Sep; 32(9):2837-50. PubMed ID: 26017300
[TBL] [Abstract][Full Text] [Related]
2. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
[TBL] [Abstract][Full Text] [Related]
3. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
4. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
5. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
[No Abstract] [Full Text] [Related]
6. Comparison of PLA microparticles and alum as adjuvants for H5N1 influenza split vaccine: adjuvanticity evaluation and preliminary action mode analysis.
Zhang W; Wang L; Liu Y; Chen X; Li J; Yang T; An W; Ma X; Pan R; Ma G
Pharm Res; 2014 Apr; 31(4):1015-31. PubMed ID: 24170280
[TBL] [Abstract][Full Text] [Related]
7. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
[TBL] [Abstract][Full Text] [Related]
8. Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy.
Joshi VB; Adamcakova-Dodd A; Jing X; Wongrakpanich A; Gibson-Corley KN; Thorne PS; Salem AK
AAPS J; 2014 Sep; 16(5):975-85. PubMed ID: 24981892
[TBL] [Abstract][Full Text] [Related]
9. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.
San Román B; Gómez S; Irache JM; Espuelas S
J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433
[TBL] [Abstract][Full Text] [Related]
10. Improving adjuvanticity of quaternized chitosan-based microgels for H5N1 split vaccine by tailoring the particle properties to achieve antigen dose sparing effect.
Wang YQ; Fan QZ; Liu Y; Yue H; Ma XW; Wu J; Ma GH; Su ZG
Int J Pharm; 2016 Dec; 515(1-2):84-93. PubMed ID: 27697632
[TBL] [Abstract][Full Text] [Related]
11. Adjuvanticity Regulation by Biodegradable Polymeric Nano/microparticle Size.
Jia J; Zhang W; Liu Q; Yang T; Wang L; Ma G
Mol Pharm; 2017 Jan; 14(1):14-22. PubMed ID: 28043126
[TBL] [Abstract][Full Text] [Related]
12. An immunopotentiator, ophiopogonin D, encapsulated in a nanoemulsion as a robust adjuvant to improve vaccine efficacy.
Tong YN; Yang LY; Yang Y; Song Z; Peng LS; Gao JN; Zeng H; Zou QM; Sun HW; Mao XH
Acta Biomater; 2018 Sep; 77():255-267. PubMed ID: 30031164
[TBL] [Abstract][Full Text] [Related]
13. Surface-assembled poly(I:C) on PEGylated PLGA microspheres as vaccine adjuvant: APC activation and bystander cell stimulation.
Hafner AM; Corthésy B; Textor M; Merkle HP
Int J Pharm; 2016 Nov; 514(1):176-188. PubMed ID: 27863662
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
Jin JW; Tang SQ; Rong MZ; Zhang MQ
Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
[TBL] [Abstract][Full Text] [Related]
15. Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery.
Diwan M; Elamanchili P; Cao M; Samuel J
Curr Drug Deliv; 2004 Oct; 1(4):405-12. PubMed ID: 16305402
[TBL] [Abstract][Full Text] [Related]
16. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
Singh D; Somani VK; Aggarwal S; Bhatnagar R
Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
[TBL] [Abstract][Full Text] [Related]
17. Robust mucosal and systemic responses against HTLV-1 by delivery of multi-epitope vaccine in PLGA nanoparticles.
Kabiri M; Sankian M; Sadri K; Tafaghodi M
Eur J Pharm Biopharm; 2018 Dec; 133():321-330. PubMed ID: 30408519
[TBL] [Abstract][Full Text] [Related]
18. Polyelectrolyte LbL microcapsules versus PLGA microparticles for immunization with a protein antigen.
De Temmerman ML; Rejman J; Vandenbroucke RE; De Koker S; Libert C; Grooten J; Demeester J; Gander B; De Smedt SC
J Control Release; 2012 Mar; 158(2):233-9. PubMed ID: 22063002
[TBL] [Abstract][Full Text] [Related]
19. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
[TBL] [Abstract][Full Text] [Related]
20. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]